SKYE
Skye Bioscience, Inc.
1.70$
-1.8%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.80 | 79.50 | – | – | – | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 1.25 | 30.72 | – | 1.17 | 1.50 | 0.53 | 0.02 | 0.02 | 0.02 | 0.17 | 0.00 | 0.14 | 0.07 | 0.15 | |
| 2.55 | 48.78 | – | -1.17 | -1.50 | -0.53 | -0.02 | -0.02 | -0.02 | -0.17 | 0.00 | -0.14 | -0.07 | -0.15 | |
| – | – | 43.33 | 67.53 | 94.31 | 20.62 | 5.02 | 33.62 | 16.80 | 14.42 | 0.01 | 6.65 | 4.10 | 8.54 | |
| 1.49 | 28.16 | 476.86 | 438.52 | 354.73 | 235.03 | 66.38 | 66.09 | 37.55 | 24.18 | 0.01 | 8.97 | 3.89 | 3.19 | |
| 1.58 | 50.47 | 520.28 | 506.05 | 449.03 | 255.63 | 71.41 | 99.74 | 54.34 | 38.60 | 0.04 | 39.66 | 6.62 | 11.59 | |
| 0.96 | -1.69 | -520.28 | -506.05 | -449.03 | -255.63 | -71.41 | -99.74 | -54.35 | -38.60 | -0.04 | -39.66 | -6.62 | -11.73 | |
| 0.15 | 0.50 | – | 61.23 | 0.00 | 0.04 | 1.44 | 15.05 | 6.10 | 3.78 | 0.00 | 1.03 | 0.21 | 0.00 | |
| 1.11 | -0.88 | -520.28 | -567.28 | -318.97 | -204.89 | -292.03 | 15.83 | -56.69 | -41.91 | -0.04 | -42.98 | -5.82 | -11.28 | |
| 0.06 | -0.81 | 0.48 | 0.20 | 0.16 | 0.11 | 0.02 | 0.02 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 1.05 | -28.16 | -520.66 | -567.48 | -319.17 | -204.95 | -292.04 | 15.82 | -56.70 | -41.92 | -0.04 | -42.99 | -5.83 | -11.28 | |
| 1.11 | 2.16 | – | – | – | -204.29 | -71.38 | 30.72 | -50.56 | -37.97 | -0.04 | -41.82 | -5.55 | -11.13 |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.